(Q41889294)

English

Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials

scientific article published on August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 October 2017

Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials (English)

1 reference

Europe PubMed Central

13 October 2017

1 reference

based on heuristic

inferred from title

author name string

Bokemeyer C

1

1 reference

Europe PubMed Central

13 October 2017

Kollmannsberger C

2

1 reference

Europe PubMed Central

13 October 2017

Stenning S

3

1 reference

Europe PubMed Central

13 October 2017

Hartmann JT

4

1 reference

Europe PubMed Central

13 October 2017

Horwich A

5

1 reference

Europe PubMed Central

13 October 2017

Clemm C

6

1 reference

Europe PubMed Central

13 October 2017

Gerl A

7

1 reference

Europe PubMed Central

13 October 2017

Meisner C

8

1 reference

Europe PubMed Central

13 October 2017

Rückerl CP

9

1 reference

Europe PubMed Central

13 October 2017

Schmoll HJ

10

1 reference

Europe PubMed Central

13 October 2017

Kanz L

11

1 reference

Europe PubMed Central

13 October 2017

Oliver T

12

1 reference

Europe PubMed Central

13 October 2017

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

13 October 2017

British Journal of Cancer

1 reference

Europe PubMed Central

13 October 2017

91

1 reference

Europe PubMed Central

13 October 2017

683-687

1 reference

Europe PubMed Central

13 October 2017

4

1 reference

Europe PubMed Central

13 October 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602020

0 references

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364800

5 June 2018

Treatment of testicular cancer: a new and improved model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364800

5 June 2018

Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364800

18 August 2018

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364800

30 September 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6602020

21 January 2018

Alternatives to radiotherapy in the management of seminoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15266338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The activity of single-agent carboplatin in advanced seminoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15266338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testicular germ-cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15266338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-agent carboplatinum for advanced seminoma. A phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15266338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15266338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Resear

1 reference

https://pubmed.ncbi.nlm.nih.gov/15266338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15266338

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6602020

0 references

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

13 October 2017

1 reference

Europe PubMed Central

13 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41889294&oldid=1568148146"